Release Date: 30/10/13 09:40 Summary: September 2013 Quarterly Activities Report Price Sensitive: Yes Download Document 1.04MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%